Robert Wenham
@RMWenham
Department Chair and Director of Research for Gynecologic Oncology at the Moffitt Cancer Center. Tweets are my views, not MCC's, and are not medical advice.
Thank you Dr Greg Sawyer and his colleagues to make this happen. Better tools, faster progress! @ProfGregSawyer @MoffittGYNONC @MoffittNews
Moffitt is proud to be the first standalone cancer center in the world to open a Nikon Center of Excellence!
Karen Lu, MD, (@karenluMD) has always been passionate about women’s health, leading her to a career in OBGYN and later oncology specializing in ovarian and gynecologic cancers. As part of our Women in Oncology series, she shares insights on mentorship, resiliency and advice for…
When we invest in learning, we invest in better outcomes for providers, patients, and our field. Our newly revealed strategic plan builds on past momentum and sets a bold path forward for gynecologic oncology.
Hands-on surgical mentorship in action. 📍Ahmadu Bello University Teaching Hospital (ABUTH) located in Zaria, Nigeria As part of the IGCS Global Fellowship Program, Prof. Matthew Schlumbrecht returns annually to work side by side with the #FellowsofIGCS in their own…
Amen. Best, brightest, and broadest we can unite will lead to greater progress for cancer patients. @MoffittGYNONC @MoffittNews @SGO_org
Physician in Chief @karenluMD Stresses Need for All Talents in Medicine | Moffitt moffitt.org/endeavor/archi…
CONGRATULATIONS!! The majority of “Tampa Top GYN ONC Doctors” are at MOFFITT. Only center with more than 1, we had FIVE! Congratulations Drs Monica Avila, Jeannie Chern, HyeSook Chon, Mitch Hoffman, & Robert Wenham. @MoffittNews @MoffittGYNONC @MAvilaMD @JeannieChern #gyncancer
Honored to be recognized among many wonderful peers! Thank you, @TBBJnewsroom!
Join us in congratulating Moffitt Cancer Center President and CEO, Patrick Hwu, MD, for being recognized by his peers and the Tampa Bay Business Journal as one of Tampa Bay’s 2025 Most Admired CEOs. This recognition reflects his leadership in advancing Moffitt as Florida’s…
We need to be fully committed to reversing this ASAP!
Uterine cancer cases in the U.S. will rise significantly by 2050, with Black women three times more likely to die from it, a study published by the American Association for Cancer Research projects. abcnews.link/8pn8FbV
Dr @JeannieChern has been selected for @MoffittNews Cancer Center Leadership Academy this year. This small group signifies those who will take medicine forward with their special skills. Congratulations Dr Chern! @SGO_org
In case you missed it, on the latest episode of my podcast, The ImmunoVerse, I sat down with Dr. Jim Mulé (@DrJamesMule), a true #immunotherapy pioneer. From our time @theNCI, to today’s breakthroughs @MoffittNews, Dr. Mulé reflects on the team that helped change cancer care…
Thank you to my anonymous nominator, the referees, and members electing me into The Academy of Science, Engineering and Medicine of Florida #ASEMFL! Joining 255 in #Florida ever honored and 1st representing #Moffitt @MoffittNews @MoffittGYNONC asemfl.org
We are honored to have Dr. @RMWenham as one of our esteemed Speakers at our upcoming Annual Conference Ovarcoming Cancer on September 18-19. Registrations opening soon - stay tuned! Be Empowered with Knowledge at #OvarCon25!
#FollowFriday Meet Robert Wenham, MD (@RMWenham), chair of gynecological oncology at Moffitt. He specializes in complex cancers and is a leader in pelvic exenteration surgery, offering hope for hard-to-treat cases. A strong advocate for research and clinical trials, he’s…
#FollowFriday Meet Robert Wenham, MD (@RMWenham), chair of gynecological oncology at Moffitt. He specializes in complex cancers and is a leader in pelvic exenteration surgery, offering hope for hard-to-treat cases. A strong advocate for research and clinical trials, he’s…
Check out the latest episode of #TheImmunoVerse podcast! 🎙️
🚨 New episode of #TheImmunoVerse podcast is live! I had the honor of speaking with @DrJamesMule, a true pioneer in cell therapy and cancer immunology @MoffittNews. In this episode, he talks about carrying immunotherapy, particularly T cell therapy, from skepticism to standard…
Rob Coleman summarizing whack a mole for PROC #ESMOGynae25 @MoffittGYNONC @rcoledude
Yes. We are in a new era of care. POLe seems to often cause carrier mutations in p53, BRCA, etc. making it the dominate force for prognosis and hopefully allowing us to limit adjuvant therapy and prevent harm of therapy. Thanks for post @medoncodoc @MoffittNews
🧬 POLEmut in Endometrial Cancer: Mutation Patterns & Prognosis 🧬 Study from Taiwan (n=100) reveals: 🔹 POLE exonuclease domain mutations (POLEmut) linked to: • ↑ Tumor mutation burden (p<0.0001) • Distinct mutation patterns in driver genes – Tumor suppressors (e.g.…